Mitokor, a biotech firm developing drugs to treat Alzheimer's and Parkinson's disease, withdrew its IPO on Monday citing unfavorable market conditions. RBC Capital Markets was the lead manager for this deal.
IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
